ArticleCancer management and research2022

Thromboembolic Events in Patients with HER2-Negative, Hormone Receptor-Positive, Metastatic Breast Cancer Treated with Ribociclib Combined with Letrozole or Fulvestrant: A Real-World Data.

Hikmat Abdel-Razeq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.